BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20220101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230627
DTEND;VALUE=DATE:20230630
DTSTAMP:20260516T063437
CREATED:20230207T095639Z
LAST-MODIFIED:20230207T095639Z
UID:36549-1687824000-1688083199@www.pharmajournalist.com
SUMMARY:3rd Annual Next Generation Gene Therapy Vectors Summit
DESCRIPTION:As the biggest industry-led meeting on novel vector development\, the 3rd Annual Next Generation Gene Therapy Vectors Summit (June 27-29\, 2023 | Boston\, MA) will bring together 100+ key opinion leaders to help solve the safety\, efficiency\, and scalability challenges of the next generation of vectors. \nIndustry heavyweights such as Novartis\, Spark Therapeutics\, Capsida Biotherapeutics\, and Dyno Therapeutics will deliver data-led seminars\, workshops\, and panels to aid in the progression of promising vector designs from discovery to clinical trials. \nDownload the brochure to see the full agenda – https://ter.li/b6qdwn \nUniting industry pioneers such as Dave Chu (Capsida Biotherapeutics)\, Sean Armour (Spark Therapeutics)\, Eric Kelsic (Dyno Therapeutics)\, Jing Liao (Alexion Pharmaceuticals)\, and others – this summit will be your ultimate roadmap to the future of the industry as it upgrades to the next generation of vectors. \nRegister to attend with your colleagues and get up to 20% off your tickets – https://ter.li/qlplw9
URL:https://www.pharmajournalist.com/event/3rd-annual-next-generation-gene-therapy-vectors-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20230628
DTEND;VALUE=DATE:20230701
DTSTAMP:20260516T063437
CREATED:20230413T095125Z
LAST-MODIFIED:20230413T095125Z
UID:37050-1687910400-1688169599@www.pharmajournalist.com
SUMMARY:8th Microbiome Movement Drug Development Summit
DESCRIPTION:The 8th Microbiome Movement Drug Development Summit returns in 2023 as North America’s definitive microbiome drug development event – and it’s back bigger and better than ever! \nThe microbiome-based therapeutic market is rapidly evolving\, and it’s more important than ever to showcase the efficacy of microbial-based approaches beyond C. difficile. Discover how drug developers are advancing their understanding of the role of the microbiome in disease and harnessing functionally relevant microbes for live biotherapeutic approaches. \nJoin us\, as we provide in-depth insights into the interactions between the microbiome and metabolic pathways\, host-microbe relationships in novel preclinical models\, and the application of microbial-based biomarkers in clinical endpoints and diagnostic settings. Our sessions also cover the mechanistic rationale behind combination therapies\, new smart clinical trial data\, and GMP compliant manufacturing for stable products. \nWith more speakers\, content\, and networking than ever before\, this is set to be the best version of the event yet and you cannot afford to miss it! \nTo know more visit: https://microbiome-summit.com/
URL:https://www.pharmajournalist.com/event/8th-microbiome-movement-drug-development-summit/
LOCATION:Omni Boston Hotel at the Seaport\, 450 Summer Street\, Boston\, MA\, 02210\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR